Showing 1 - 20 results of 29 for search 'Egbert F. Smit', query time: 0.05s
Refine Results
-
1
Review: Angiogenesis inhibitors in the treatment of non-small cell lung cancer by Joline S.W. Lind, Egbert F. Smit
Published 2009-09-01
Article -
2
BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape by David Planchard, Rachel E. Sanborn, Marcelo V. Negrao, Aria Vaishnavi, Egbert F. Smit
Published 2024-04-01
Article -
3
Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells by Maxime Blijlevens, Malgorzata A. Komor, Rocco Sciarrillo, Egbert F. Smit, Remond J. A. Fijneman, Victor W. van Beusechem
Published 2020-06-01
Article -
4
-
5
-
6
Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical Resistance by Richard J. Honeywell, Ietje Kathmann, Elisa Giovannetti, Carmelo Tibaldi, Egbert F. Smit, Maria N. Rovithi, Henk M.W. Verheul, Godefridus J. Peters
Published 2020-11-01
Article -
7
-
8
Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients by Guilherme D. Kolinger, David Vállez García, Gerbrand M. Kramer, Virginie Frings, Egbert F. Smit, Adrianus J. de Langen, Rudi A. J. O. Dierckx, Otto S. Hoekstra, Ronald Boellaard
Published 2019-02-01
Article -
9
A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV no... by Hanieh Abedian Kalkhoran, Juliëtte Zwaveling, Bert N. Storm, Sylvia A. van Laar, Johanneke EA Portielje, Henk Codrington, Dieuwke Luijten, Pepijn Brocken, Egbert F. Smit, Loes E. Visser
Published 2023-03-01
Article -
10
Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis by Deirdre M.H.J. ten Berge, Daniel P. Hurkmans, Ilse den Besten, Jeroen S. Kloover, Ron H.J. Mathijssen, Reno Debets, Egbert F. Smit, Joachim G.J.V. Aerts
Published 2019-12-01
Article -
11
Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer patients: a pilot study with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography. by Virginie Frings, Astrid A M van der Veldt, Ronald Boellaard, Gerarda J M Herder, Elisa Giovannetti, Richard Honeywell, Godefridus J Peters, Erik Thunnissen, Otto S Hoekstra, Egbert F Smit
Published 2013-01-01
Article -
12
-
13
Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine by Krijn K. Dijkstra, Kim Monkhorst, Luuk J. Schipper, Koen J. Hartemink, Egbert F. Smit, Sovann Kaing, Rosa de Groot, Monika C. Wolkers, Hans Clevers, Edwin Cuppen, Emile E. Voest
Published 2020-05-01
Article -
14
Peptide-mediated ‘miniprep’ isolation of extracellular vesicles is suitable for high-throughput proteomics by Jaco C. Knol, Inge de Reus, Tim Schelfhorst, Robin Beekhof, Meike de Wit, Sander R. Piersma, Thang V. Pham, Egbert F. Smit, Henk M.W. Verheul, Connie R. Jiménez
Published 2016-06-01
Article -
15
Correction: Clonality analysis of pulmonary tumors by genome-wide copy number profiling. by Julien P L Vincenten, Hendrik F van Essen, Birgit I Lissenberg-Witte, Nicole W J Bulkmans, Oscar Krijgsman, Daoud Sie, Paul P Eijk, Egbert F Smit, Bauke Ylstra, Erik Thunnissen
Published 2019-01-01
Article -
16
-
17
Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target. by Mariëlle I Gallegos Ruiz, Karijn Floor, Paul Roepman, José A Rodriguez, Gerrit A Meijer, Wolter J Mooi, Ewa Jassem, Jacek Niklinski, Thomas Muley, Nico van Zandwijk, Egbert F Smit, Kristin Beebe, Len Neckers, Bauke Ylstra, Giuseppe Giaccone
Published 2008-03-01
Article -
18
Increased Expression of the EZH2 Polycomb Group Gene in BMI-1-Positive Neoplastic Cells during Bronchial Carcinogenesis by Roderick H.J. Breuer, Peter J.F. Snijders, Egbert F. Smit, Thomas G. Sutedja, Richard G.A.B. Sewalt, Arie P. Otte, Folkert J. van Kemenade, Pieter E. Postmus, Chris J.L.M. Meijer, Frank M. Raaphorst
Published 2004-11-01
Article -
19
Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report by Myriam Mirza, Aseem Shrivastava, Cecile Matthews, Natasha Leighl, Calvin S. H. Ng, David Planchard, David Planchard, Sanjay Popat, Sanjay Popat, Sanjay Popat, Julia Rotow, Egbert F. Smit, Ross Soo, Masahiro Tsuboi, Fan Yang, Brendon Stiles, Christian Grohe, Yi-Long Wu
Published 2024-01-01
Article -
20
Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients by Ekaterina A. Semenova, Min-chul Kwon, Kim Monkhorst, Ji-Ying Song, Rajith Bhaskaran, Oscar Krijgsman, Thomas Kuilman, Dennis Peters, Wieneke A. Buikhuisen, Egbert F. Smit, Colin Pritchard, Miranda Cozijnsen, Jan van der Vliet, John Zevenhoven, Jan-Paul Lambooij, Natalie Proost, Erwin van Montfort, Arno Velds, Ivo J. Huijbers, Anton Berns
Published 2016-07-01
Article